International Stem Cell Corporation launches skin care line in the US

By Simon Pitman

- Last updated on GMT

Related tags Skin care Stem cell Lifeline skin care

The Lifetime Skin Care line from the International Stem Cell Corporation has gone on sale in the US, thought to be one of the first anti-aging lines to incorporate stem cell technology.

The launch will include two products, consisting of a defensive Day Moisture Serum, and Recovery Night Moisture Serum, which will be distributed at select retail outlets in the US as well as online.

Previously the products had been soft launched to organizations and select consumers that had previously shown an interest in the product line and the technology the company has developed for the formula.

“Because the quality products Lifeline Skin Care offers are experiencing strong demand and the human stem cell extracts require innovative manufacturing processes, we chose to develop our sales channels gradually and incrementally,”​ said Lifeline Skin Care CEO, Dr. Ruslan Semechkin.

Joint venture project

International Stem Cell Corporation announced the joint venture to launch a line of skin care products based on technology that has reproduced embryonic stem cells earlier this year.

The skin care line line is the result of a joint marketing venture with industry expert John Maudlin, and the new line has been developed by Lifeline Skin Care, a subsidiary of International Stem Cell.

The new line is said to have been in development for well over a year and involves a technologically advanced formulation for skin rejuvenation crèmes, developed using ‘parthenogenetic’ stem cells, developed without the use of fertilized embryos by Lifeline Skin Care.

Rejuvenation properties discovered during research

The company says that the rejuvenation properties of the stem cells were discovered during its therapeutic stem cells research, which triggered the development of the skin care line.

The company says that one of the biggest development challenges was finding a way to surround the stem cell proteins with a nano-vesicle. Such a technology has been successfully incorporated into the cells to extend shelf life and enhance the delivery of the product to the skin, the company claims.

“This represents an amazing leap forward in the combination of a variety of cutting edge technologies to yield products that have the potential to find significant consumer acceptance,”​ said Aldrich.

The company had previously announced that it would be launching the skin care line in October in the US market, but that launch date was put back to November to allow the company to meet anticipated product demand.

The initial product offering involved 1.5 million potential consumers from the company’s database, combined with the extended database provided by Maudlin.

Related topics Market Trends

Related news